Latest news for Lotus Pharma (OTC:LTUS) Stock

Lotus Pharmaceuticals is a development stage company.

News

LTUS

Lotus Pharmaceuticals Announces New Patent for Diabetes Drug 

LOTUS PHARMS INC by Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals

<p>Lotus Pharmaceuticals, Inc. (LTUS) announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. </p>
<p>The patent covers the composition and preparation methods for the drug through 2030.</p>


Lotus Pharma

Lotus Pharmaceuticals, Inc. (LTUS) announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. 

The patent covers the composition and preparation methods for the drug through 2030.


Comments

Lotus Pharma

News

Latest news for Lotus Pharma (OTC:LTUS) Stock

Tuesday, October 19, 2010

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga